Follow Us
© 2026 Arizent. All rights reserved.
Alexandra Michailov is a partner at Shulman Rogers a full service law firm outside Washington, DC. She brings a decade-long record of providing strategic counseling and advice to corporate and … Read full bio
For reprint and licensing requests for this article, click here.
Open enrollment doesn’t have to overwhelm employees. Collective Health’s Jacque Ludwig shares how employers can drive engagement and make benefits easier to navigate.
While the legislation's future is still unclear, there are many important things for leaders to know.
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Employers are under pressure to keep benefits competitive while controlling costs, driving new scrutiny of PBMs, hospital prices and GLP-1 coverage for 2027.
